Participants' comments highlighted the importance of developing and maintaining good patient/healthcare provider relationships and tailoring communication styles to the preferences of patients.
See the article here.
Medication nonadherence remains an unresolved public health issue in the United States and is a significant source of morbidity, mortality, and increased healthcare costs for patients with chronic disease states.
Studies assessing adherence to chronic medications have reported an average adherence rate of 50%.
Failure to adhere to prescribed medication regimens costs the US health care system more than $100 billion each year for otherwise avoidable hospitalizations.
See study here
They found with a population of over 567,000, sample sizes for each drug category and their associated total cost of care savings – from moving someone with low adherence (<50%) to near perfect adherence (99%+) – was as follows:
- RAS: 132,358 in the sample, achieving $2,901 potential savings PPPY
- Statin: 145,038 in the sample, achieving $1,563 potential savings PPPY
- Diabetes: 40,407 in the sample, achieving $3,365 potential savings PPPY
Additionally, the study found lower odds of hospitalizations and emergency room visits were associated with improved drug category adherence.